MetaADEDB 2.0 @ LMMD
Lignospan
(FMDUVJYVAXFKIH-QKWFRNNBSA-N)
Structure
SMILES
CCN(CC(=O)Nc1c(C)cccc1C)CC.CNC[C@@H](c1ccc(c(c1)O)O)O.Cl
Molecular Formula:
C23H36ClN3O4
Molecular Weight:
454.003
Log P:
4.2002
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
6
TPSA:
105.06
CAS Number(s):
55947-85-8
Synonym(s)
1.
Lignospan
External Link(s)
PubChem Compound3043678
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Anaphylactic shockFAERS: 5US FAERS
2Drug ineffectiveFAERS: 4US FAERS
3ShockFAERS: 4US FAERS
4TremorFAERS: 4US FAERS
5PainFAERS: 3US FAERS
6PalpitationsFAERS: 3US FAERS
7Angina PectorisFAERS: 2US FAERS
8AngioedemaFAERS: 2US FAERS
9CellulitisFAERS: 2US FAERS
10CyanosisFAERS: 2US FAERS
11Depressed Level of ConsciousnessFAERS: 2US FAERS
12HypersensitivityFAERS: 2US FAERS
13NauseaFAERS: 2US FAERS
14AbscessFAERS: 1US FAERS
15AkinesiaFAERS: 1US FAERS
16Device breakageFAERS: 1US FAERS
17DiplopiaFAERS: 1US FAERS
18Drug administration errorFAERS: 1US FAERS
19EpilepsyFAERS: 1US FAERS
20Eyelids pruritusFAERS: 1US FAERS
21Feeling abnormalFAERS: 1US FAERS
22HeadacheFAERS: 1US FAERS
23InfectionFAERS: 1US FAERS
24Intentional product use issueFAERS: 1US FAERS
25Memory impairmentFAERS: 1US FAERS
26Metastatic NeoplasmFAERS: 1US FAERS
27MydriasisFAERS: 1US FAERS
28No adverse eventFAERS: 1US FAERS
29Oculomucocutaneous syndromeFAERS: 1US FAERS
30OphthalmoplegiaFAERS: 1US FAERS
31PO2 decreasedFAERS: 1US FAERS
32Post procedural painFAERS: 1US FAERS
33Procedural complicationFAERS: 1US FAERS
34Product use in unapproved indicationFAERS: 1US FAERS
35RalesFAERS: 1US FAERS
36Skin necrosisFAERS: 1US FAERS
37Visual disturbanceFAERS: 1US FAERS
38VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.